137 related articles for article (PubMed ID: 23364142)
1. High serum YKL-40 level in patients with COPD is related to hypoxemia and disease severity.
Gumus A; Kayhan S; Cinarka H; Kirbas A; Bulmus N; Yavuz A; Sahin U; Ozkaya S
Tohoku J Exp Med; 2013 Feb; 229(2):163-70. PubMed ID: 23364142
[TBL] [Abstract][Full Text] [Related]
2. Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.
Holmgaard DB; Mygind LH; Titlestad IL; Madsen H; Pedersen SS; Johansen JS; Pedersen C
BMC Pulm Med; 2013 Dec; 13():77. PubMed ID: 24373580
[TBL] [Abstract][Full Text] [Related]
3. YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling.
Lai T; Wu D; Chen M; Cao C; Jing Z; Huang L; Lv Y; Zhao X; Lv Q; Wang Y; Li D; Wu B; Shen H
Respir Res; 2016 Mar; 17():31. PubMed ID: 27013031
[TBL] [Abstract][Full Text] [Related]
4. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages.
Létuvé S; Kozhich A; Arouche N; Grandsaigne M; Reed J; Dombret MC; Kiener PA; Aubier M; Coyle AJ; Pretolani M
J Immunol; 2008 Oct; 181(7):5167-73. PubMed ID: 18802121
[TBL] [Abstract][Full Text] [Related]
5. Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease.
Otsuka K; Matsumoto H; Niimi A; Muro S; Ito I; Takeda T; Terada K; Yamaguchi M; Matsuoka H; Jinnai M; Oguma T; Nakaji H; Inoue H; Tajiri T; Iwata T; Chin K; Mishima M
Respiration; 2012; 83(6):507-19. PubMed ID: 21968467
[TBL] [Abstract][Full Text] [Related]
6. Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.
James AJ; Reinius LE; Verhoek M; Gomes A; Kupczyk M; Hammar U; Ono J; Ohta S; Izuhara K; Bel E; Kere J; Söderhäll C; Dahlén B; Boot RG; Dahlén SE;
Am J Respir Crit Care Med; 2016 Jan; 193(2):131-42. PubMed ID: 26372680
[TBL] [Abstract][Full Text] [Related]
7. YKL-40: may be use as a new inflammatory biomarker in obstructive sleep apnea syndrome?
Duru S; Yüce G; Fırat H; Şimşek B; Uçar F; Ardıç S; Kurt EB
Tuberk Toraks; 2015 Sep; 63(3):158-64. PubMed ID: 26523896
[TBL] [Abstract][Full Text] [Related]
8. The relationship between serum YKL-40 levels and severity of asthma.
Duru S; Yüce G; Ulasli SS; Erdem M; Kizilgün M; Kara F; Ardıc S
Iran J Allergy Asthma Immunol; 2013 Jul; 12(3):247-53. PubMed ID: 23893808
[TBL] [Abstract][Full Text] [Related]
9. Regulation of YKL-40 expression by corticosteroids: effect on pro-inflammatory macrophages in vitro and its modulation in COPD in vivo.
Kunz LI; van't Wout EF; van Schadewijk A; Postma DS; Kerstjens HA; Sterk PJ; Hiemstra PS
Respir Res; 2015 Dec; 16():154. PubMed ID: 26696093
[TBL] [Abstract][Full Text] [Related]
10. Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome.
Bakırcı EM; Ünver E; Değirmenci H; Kıvanç T; Günay M; Hamur H; Büyüklü M; Ceyhun G; Topal E; Çoban TA
Turk Kardiyol Dern Ars; 2015 Jun; 43(4):333-9. PubMed ID: 26142786
[TBL] [Abstract][Full Text] [Related]
11. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome.
Wang X; Xing GH
Scand J Clin Lab Invest; 2014 Jan; 74(1):74-8. PubMed ID: 24405178
[TBL] [Abstract][Full Text] [Related]
12. Association of serum YKL-40 with the presence and severity of obstructive sleep apnea syndrome.
Li W; Yu Z; Jiang C
Lab Med; 2014; 45(3):220-5. PubMed ID: 25051073
[TBL] [Abstract][Full Text] [Related]
13. YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment.
Lai T; Chen M; Deng Z; L Y; Wu D; Li D; Wu B
BMC Pulm Med; 2015 Jan; 15():1. PubMed ID: 25578181
[TBL] [Abstract][Full Text] [Related]
14. Correlation of serum vascular adhesion protein-1 with airflow limitation and quality of life in stable chronic obstructive pulmonary disease.
Amani M; Ghadimi N; Aslani MR; Ghobadi H
Respir Med; 2017 Nov; 132():149-153. PubMed ID: 29229088
[TBL] [Abstract][Full Text] [Related]
15. The relation of circulating YKL-40 to levels and decline of lung function in adult life.
Guerra S; Halonen M; Sherrill DL; Venker C; Spangenberg A; Carsin AE; Tarès L; Lavi I; Barreiro E; Martínez-Moratalla J; Urrutia I; Sunyer J; Antó JM; Martinez FD
Respir Med; 2013 Dec; 107(12):1923-30. PubMed ID: 23920328
[TBL] [Abstract][Full Text] [Related]
16. Association of serum YKL-40 levels with the presence and severity of coronary artery disease in patients with obstructive sleep apnea syndrome.
Sui X; Gao C
Clin Invest Med; 2013 Dec; 36(6):E306-11. PubMed ID: 24309227
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
[TBL] [Abstract][Full Text] [Related]
18. The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review.
Tong X; Wang D; Liu S; Ma Y; Li Z; Tian P; Fan H
Int J Chron Obstruct Pulmon Dis; 2018; 13():409-418. PubMed ID: 29430175
[TBL] [Abstract][Full Text] [Related]
19. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
[TBL] [Abstract][Full Text] [Related]
20. Correlation between serum YKL-40 (chitinase-3-like protein 1) level and proteinuria in renal transplant recipients.
Tatar E; Gungor O; Celtik A; Sisman AR; Yaprak M; Asci G; Ozkahya M; Toz H
Ann Transplant; 2013 Mar; 18():95-100. PubMed ID: 23792508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]